鼻病毒感染对健康的影响研究
摘要
济成本和社会资源消耗方面与流感和呼吸道合胞病毒等其他呼吸道病毒的负担相当。鼻病毒分 3 型 169 个亚型，在肠道病
毒属中呈现出最大的多样性，然而，型和亚型在 RV 感染临床结果中的作用仍不清楚。本综述旨在收集与 RV 疾病相关的
数据，以便找到临床结果与型和 / 或亚型的联系，以指导制定针对性的预防和治疗等相关措施。
关键词
全文:
PDF参考
[1]Principi N., Zampiero A., Gambino M., Scala A., Senatore
L., Lelii M., Ascolese B., Pelucchi C., Esposito S. Prospective
evaluation of rhinovirus infection in healthy young children. J.
Clin. Virol. 2015;66:83–89.
[2]Fine J., Bray-Aschenbrenner A., Williams H., Buchanan
P., Werner J. The Resource Burden of Infections with Rhinovirus/
Enterovirus, Influenza, and Respiratory Syncytial Virus in
Children. Clin. Pediatr. 2019;58:177–184.
[3]Greenberg S.B. Respiratory Consequences of Rhinovirus
Infection. Arch. Intern. Med. 2003;163:278–284. doi: 10.1001/
archinte.163.3.278.
[4] 王擎 , 罗明 , 王雪 , 黄芳 , 龚成 . 人鼻病毒的研究进展 .
中华实验和临床病毒学杂志 . 2023; 37: 216-221.
[5]Winther B., McCue K., Ashe K., Rubino J., Hendley J.
Rhinovirus contamination of surfaces in homes of adults with
natural colds: Transfer of virus to fingertips during normal daily
activities. J. Med. Virol. 2011;83:906–909.
[6]Liu L., Li Y., Nielsen P.V., Wei J., Jensen R.L. Shortrange airborne transmission of expiratory droplets between two
people. Indoor Air. 2016;27:452–462.
[7]Chen W.J., Arnold J.C., Fairchok M.P., Danaher P.J.,
McDonough E.A., Blair P.J., Garcia J., Halsey E.S., Schofield
C., Ottolini M., et al. Epidemiologic, clinical, and virologic
characteristics of human rhinovirus infection among otherwise
healthy children and adults: Rhinovirus among adults and
children. J. Clin. Virol. 2015;64:74–82.
[8] 常颖 , 黄光举 , 张慧玉 , 李娟 , 徐静 . 儿童呼吸系统
鼻病毒感染流行特征分析 . 2024; 19:312-315.
[9]Hayden F.G. Rhinovirus and the lower respiratory tract.
Rev. Med. Virol. 2004;14:17–31. doi: 10.1002/rmv.406.
[10]Walker E., Ison M.G. Respiratory viral infections among
hospitalized adults: Experience of a single tertiary healthcare
hospital. Influ. Other Respir. Viruses. 2014;8:282–292.
[11] 程利红 , 刘莉 , 梁胜楠 , 钱璐 , 周璞 , 张金忠 , 杜银菊 .
2016 ～ 2018 年聊城市部分儿童社区获得性肺炎患者的病原
体分布及耐药性分析 . 预防医学论坛 . 2021; 27: 410-412,419.
[12]Schilder A.G., Chonmaitree T., Cripps A.W., Rosenfeld
R.M., Casselbrant M.L., Haggard M.P., Venekamp R.P. Otitis
media. Nat. Rev. Dis. Primers. 2016;2:16063.
[13]Adam D.C., Chen X., Scotch M., MacIntyre C.R., Dwyer
D., Kok J. The Molecular Epidemiology and Clinical Phylogenetics
of Rhinoviruses Among Paediatric Cases in Sydney, Australia. Int.
J. Infect. Dis. 2021;110:69–74.
[14]Golke P., Hönemann M., Bergs S., Liebert U.G. Human
Rhinoviruses in Adult Patients in a Tertiary Care Hospital in
Germany: Molecular Epidemiology and Clinical Significance.
Viruses. 2021;13:2027.
[15]Li W., Yu B., Zhou J., Wang Y., Xue B., Pan J., Ran Y.,
Yang X., Yang F., Li H. Genetic diversity and epidemiology of
human rhinovirus among children with severe acute respiratory
tract infection in Guangzhou, China. Virol. J. 2021;18:174.
[16]Choi T., Devries M., Bacharier L.B., Busse W., Camargo
C.A., Jr., Cohen R., Demuri G.P., Evans M.D., Fitzpatrick A.M.,
Gergen P.J., et al. Enhanced Neutralizing Antibody Responses to
Rhinovirus C and Age-Dependent Patterns of Infection. Am. J.
Respir. Crit. Care Med. 2021;203:822–830.
[17]Clark T.W., Ewings S., Medina M.-J., Batham S., Curran
M.D., Parmar S., Nicholson K.G. Viral load is strongly associated
with length of stay in adults hospitalised with viral acute
respiratory illness. J. Infect. 2016;73:598–606.
[18]Xiao Q., Zheng S., Zhou L., Ren L., Xie X., Deng Y.,
Tian D., Zhao Y., Fu Z., Li T., et al. Impact of Human Rhinovirus
Types and Viral Load on the Severity of Illness in Hospitalized
Children with Lower Respiratory Tract Infections. Pediatr. Infect.
Dis. J. 2015;34:1187–1192.
[19]Granados A., Peci A., McGeer A., Gubbay J.B. Influenza
and rhinovirus viral load and disease severity in upper respiratory
tract infections. J. Clin. Virol. 2017;86:14–19.
[20]Van der Linden L., Bruning A.H., Thomas X.V., Minnaar
R.P., Rebers S.P., Schinkel J., de Jong M.D., Pajkrt D., Wolthers
K.C. A molecular epidemiological perspective of rhinovirus types
circulating in Amsterdam from 2007 to 2012. Clin. Microbiol.
Infect. 2016;22:1002.e9–1002.e14.
[21]Morobe J.M., Nyiro J.U., Brand S., Kamau E., Gicheru E.,
Eyase F., Otieno G.P., Munywoki P.K., Agoti C., Nokes J. Human
rhinovirus spatial-temporal epidemiology in rural coastal Kenya,
2015-2016, observed through outpatient surveillance. Wellcome
Open Res. 2019;3:128.
[22]Lopes G.P., Amorim P.S., de Melo B.D.O., Maramaldo
C.E.C., Bomfim M.R.Q., Neto L.G.L., Alves M.S., Silva F.B.,
Soeiro-Pereira P.V., Falcai A. Identification and seasonality of
rhinovirus and respiratory syncytial virus in asthmatic children in
tropical climate. Biosci. Rep. 2020;40:BSR20200634.
[23]Vittucci A.C., Piccioni L., Coltella L., Ciarlitto C.,
Antilici L., Bozzola E., Midulla F., Palma P., Perno C.F., Villani
A. The Disappearance of Respiratory Viruses in Children during
the COVID-19 Pandemic. Int. J. Environ. Res. Public Health.
2021;18:9550.
[24]Mansuy J., Bourcier M., Trémeaux P., Dimeglio C.,
Izopet J. COVID-19 pandemic period, where are the seasonal
viruses? J. Med. Virol. 2021;93:4097–4098.
[25]Redlberger-Fritz M., Kundi M., Aberle S.W.,
Puchhammer-Stockl E. Significant impact of nationwide SARSCoV-2 lockdown measures on the circulation of other respiratory
virus infections in Austria. J. Clin. Virol. 2021;137:104795.
[26]Girkin J., Loo S.-L., Esneau C., Maltby S., Mercuri F.,
Chua B., Reid A.T., Veerati P.C., Grainge C.L., Wark P.A., et al.
TLR2-mediated innate immune priming boosts lung anti-viral
immunity. Eur. Respir. J. 2021;58:2001584.
[27]Glanville N., Johnston S.L. Challenges in developing
a cross-serotype rhinovirus vaccine. Curr. Opin. Virol.
2015;11:83–88.
[28]Lee S., Nguyen M.T., Currier M.G., Jenkins J.B., Strobert
E.A., Kajon A.E., Madan-Lala R., Bochkov Y.A., Gern J.E., Roy
K., et al. A polyvalent inactivated rhinovirus vaccine is broadly
immunogenic in rhesus macaques. Nat. Commun. 2016;7:12838.
[29]Hayden F.G., Herrington D.T., Coats T.L., Kim K.,
Cooper E.C., Villano S.A., Liu S., Hudson S., Pevear D.C., Collett
M., et al. Efficacy and Safety of Oral Pleconaril for Treatment
of Colds Due to Picornaviruses in Adults: Results of 2 DoubleBlind, Randomized, Placebo-Controlled Trials. Clin. Infect. Dis.
2003;36:1523–1532.
[30]Lanko K., Sun L., Froeyen M., Leyssen P., Delang L.,
Mirabelli C., Neyts J. Comparative analysis of the molecular
mechanism of resistance to vapendavir across a panel of
picornavirus species. Antivir. Res. 2021;195:105177
[31]Mello C., Aguayo E., Rodriguez M., Lee G., Jordan R.,
Cihlar T., Birkus G. Multiple Classes of Antiviral Agents ExhibitIn
VitroActivity against Human Rhinovirus Type C. Antimicrob.
Agents Chemother. 2013;58:1546–1555.
[32]Djukanovic R., Harrison T., Johnston S.L., Gabbay F.,
Wark P., Thomson N.C., Niven R., Singh D., Reddel H.J., Davies
D.E., et al. The effect of inhaled IFN-beta on worsening of asthma
symptoms caused by viral infections. A randomized trial. Am. J.
Respir. Crit. Care Med. 2014;190:145–154.
[33]Proud P.C., Tsitoura D., Watson R.J., Chua B.Y., Aram
M.J., Bewley K.R., Cavell B.E., Cobb R., Dowall S., Ho C.M.K.,
et al. Prophylactic intranasal administration of a TLR2/6 agonist
reduces upper respiratory tract viral shedding in a SARS-CoV-2
challenge ferret model. EBioMedicine. 2021;63:103153.
[34]Busse W.W., Lemanske R.F., Jr., Gern J.E. Role of viral
respiratory infections in asthma and asthma exacerbations. Lancet.
2010;376:826–834.
[35]Haddad-Boubaker S., Mefteh K., Mejri C., Bouaffsoun A.,
El Moussi A., Boutiba I., Mnif K., Slim A., Kechrid A., Smaoui H.
High genotypic diversity of Rhinoviruses obtained from Tunisian
children with severe acute respiratory infection. J. Infect. Dev.
Ctries. 2021;15:726–735.
[36]Ortega H., Nickle D., Carter L. Rhinovirus and asthma:
Challenges and opportunities. Rev. Med. Virol. 2021;31:e2193.
[37]Calvo C., Aguado I., García-García M.L., RuizChercoles E., Díaz-Martinez E., Albañil R.M., Campelo O.,
Olivas A., Muñóz-Gonzalez L., Pozo F., et al. Respiratory viral
infections in a cohort of children during the first year of life and
their role in the development of wheezing. An. Pediatr. Eng. Ed.
2017;87:104–110.
[38]De Winter J.J., Bont L., Wilbrink B., van der Ent C.K.,
Smit H.A., Houben M.L. Rhinovirus wheezing illness in infancy is
associated with medically attended third year wheezing in low risk
infants: Results of a healthy birth cohort study. Immun. Inflamm.
Dis. 2015;3:398–405.
[39]Arden K.E., Faux C.E., O’Neill T., McErlean P.,
Nitsche A., Lambert S.B., Nissen M.D., Sloots T.P., Mackay
I.M. Molecular characterization and distinguishing features of
a novel human rhinovirus (HRV) C, HRVC-QCE, detected in
children with fever, cough and wheeze during 2003. J. Clin. Virol.
2010;47:219–223.
[40]Arden K.E., Chang A.B., Lambert S.B., Nissen M.D.,
Sloots T.P., Mackay I.M. Newly identified respiratory viruses in
children with asthma exacerbation not requiring admission to
hospital. J. Med. Virol. 2010;82:1458–1461.
[41]Pierangeli A., Scagnolari C., Selvaggi C., Verzaro S.,
Spina M.T., Bresciani E., Antonelli G., Bertazzoni G. Rhinovirus
frequently detected in elderly adults attending an emergency
department. J. Med. Virol. 2011;83:2043–2047.
[42]Hung I.F.N., Zhang A.J., Esposito S., Chan J.F.W.,
Zhu S.H.S., Zhang R., Chan T.-C., Chan K.-H., Yuen K.-Y.
Unexpectedly Higher Morbidity and Mortality of Hospitalized
Elderly Patients Associated with Rhinovirus Compared with
Influenza Virus Respiratory Tract Infection. Int. J. Mol. Sci.
2017;18:259.
[43]Lee N., Smith S., Zelyas N., Klarenbach S., Zapernick
L., Bekking C., So H., Yip L., Tipples G., Taylor G., et al. Burden
of noninfluenza respiratory viral infections in adults admitted to
hospital: Analysis of a multiyear Canadian surveillance cohort
from 2 centres. Can. Med. Assoc. J. 2021;193:E439–E446.
[44]Tapparel C., Cordey S., Junier T., Farinelli L., Van Belle
S., Soccal P.M., Aubert J.-D., Zdobnov E., Kaiser L. Rhinovirus
Genome Variation during Chronic Upper and Lower Respiratory
Tract Infections. PLoS ONE. 2011;6:e21163.
(7 摘要 Views, 115 PDF Downloads)
Refbacks
- 当前没有refback。